LSTA:NASDAQ
Lisata Therapeutics Inc
၃.၃၀ US$
arrow_upward
+၃.၁၂%(+၀.၁၀၀) 1D
မေ ၂၇, GMT-၄ ၁၆:၀၀:၀၀ · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for LSTA...
Open
၃.၂၀ US$
High
၃.၃၀ US$
Low
၃.၁၈ US$
Mkt. cap
၃.၀၁ ကုဋေ
Avg. vol.
၆.၈၆ သောင်း
Volume
၇.၉၅ သောင်း
52-wk high
၅.၀၆ US$
52-wk low
၁.၈၁ US$
EPS
-၁.၈၆ US$
Beta
၀.၈၁
Shares outstanding
၉.၁၁ သန်း
No. of employees
၂၁
News stories
From sources across the web
Stock Titan
·
ပြီးခဲ့သည့် ၁ နာရီ
Greenwave (NASDAQ: GWAV) faces added Nasdaq risk after multiple late SEC filings
MarketWatch
·
ပြီးခဲ့သည့် ၃၆ မိနစ်
Stocks just scored a trifecta of record closes for the first time in 2026. What to expect next.
Yahoo Finance Singapore
·
ပြီးခဲ့သည့် ၃၇ မိနစ်
FedEx Freight Holding Company Set to Join S&P 500; EPAM Systems and Dave to Join S&P SmallCap 600
Investor's Business Daily
·
ပြီးခဲ့သည့် ၂ နာရီ
Dow Jones Futures: Stocks At Highs As Oil Prices Tumble, Marvell, Snowflake Jump Late On Earnings
Profile
Lisata Therapeutics is an American clinical stage pharmaceutical company active in the field of oncology, specifically aimed at developing and commercializing new cancer therapies. It was formed through a merger of Cend Therapeutics and Caladrius Biosciences in September 2022.
In 2019, the FDA granted their product, certepetide, orphan drug status in pancreatic cancer, followed by a Fast track status in 2022. Non-clinical data collected by Lisata and others have demonstrated enhanced delivery of various existing and emerging anti-cancer therapies, including chemotherapies, immunotherapies and RNA-based therapeutics when used with certepetide. Wikipedia
About Lisata Therapeutics Inc
CEO-
Employees၂၁
Founded၁၉၈၀
HeadquartersBasking Ridge, နယူးဂျာစီပြည်နယ်, ယူနိုက်တက်စတိတ်
Sector-
Websitelisata.com
AI content may include mistakes. Learn more